Cabometyx and Urticaria - a phase IV clinical study of FDA data
Summary:
Urticaria is reported as a side effect among people who take Cabometyx (cabozantinib s-malate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Opdivo, and have Renal cell carcinoma.
The phase IV clinical study analyzes which people have Urticaria when taking Cabometyx. It is created by eHealthMe based on reports of 35,066 people who have side effects when taking Cabometyx from the FDA, and is updated regularly.
What is Cabometyx?
Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.
What is Urticaria?
Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.
35,066 people reported to have side effects when taking Cabometyx.
Among them, 74 people (0.21%) have Urticaria.

Among these 74 people:
How long have people been on Cabometyx when they have Urticaria? *
- < 1 month: 75 %
- 1 - 6 months: 25 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Urticaria when taking Cabometyx? *
- female: 45.95 %
- male: 54.05 %
What is the age of people who have Urticaria when taking Cabometyx? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 2.44 %
- 50-59: 34.15 %
- 60+: 63.41 %
What are other drugs people take besides Cabometyx? *
- Opdivo: 10 people, 13.51%
- Metformin: 6 people, 8.11%
- Losartan: 6 people, 8.11%
- Vitamins: 5 people, 6.76%
- Amlodipine: 5 people, 6.76%
- Aspirin: 5 people, 6.76%
- Vitamin D3: 4 people, 5.41%
- Vitamin B12: 4 people, 5.41%
- Klor-Con: 3 people, 4.05%
- Morphine: 3 people, 4.05%
What are other side effects people have besides Urticaria? *
- Diarrhea: 27 people, 36.49%
- Fatigue (feeling of tiredness): 26 people, 35.14%
- Rashes (redness): 21 people, 28.38%
- Weight Decreased: 20 people, 27.03%
- Nausea (feeling of having an urge to vomit): 17 people, 22.97%
- High Blood Pressure: 14 people, 18.92%
- Oral Pain: 13 people, 17.57%
- Stomatitis (inflammation of mucous membrane of mouth): 11 people, 14.86%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 10 people, 13.51%
- Itching: 10 people, 13.51%
What are the existing conditions these people have? *
- Renal Cell Carcinoma (a kidney cancer): 56 people, 75.68%
- High Blood Pressure: 3 people, 4.05%
- High Blood Cholesterol: 3 people, 4.05%
- Gastritis (inflammation of stomach): 3 people, 4.05%
- Thyroid Cancer: 2 people, 2.70%
- Metastases To Pleura (cancer spreads to pleura): 2 people, 2.70%
- Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 2.70%
- Thyroid Diseases: 1 person, 1.35%
- Sleep Disorder: 1 person, 1.35%
- Oral Cancer (mouth cancer): 1 person, 1.35%
* Approximation only. Some reports may have incomplete information.
Do you take Cabometyx and have Urticaria?
- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cabometyx:
- Cabometyx (35,069 reports)
Urticaria treatments and more:
- Urticaria (173,777 reports)
How severe was Urticaria and when was it recovered:
Expand to all the drugs that have ingredients of cabozantinib s-malate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cabometyx:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Urticaria:
- Urticaria (2,612 drugs)
Browse all the conditions that are associated with Urticaria:
- Urticaria (2,953 conditions)
Related publications that referenced our studies
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Sharma SP, Muggia F, "Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report", ecancermedicalscience, 2016 Jan .
- Musri FY, Mutlu H, K?vrak Salim D, Karakurt Ery?lmaz M, ?nal B, Tural D, ?enol Co?kun H, "Sorafenib-induced severe urticaria in a patient with hepatocellular cancer", Journal of Oncology Pharmacy Practice, 2016 Jan .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on cabozantinib s-malate (the active ingredients of Cabometyx) and Cabometyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hydroxyzine cause Ageusia? - 2 seconds ago
- Could Thiamine cause Cough Aggravated? - 2 seconds ago
- Januvia and Staphylococcal Infection for Men aged 60+ - 3 seconds ago
- Could Zofran cause Intestinal Ischaemia? - 6 seconds ago
- Could Decitabine cause Cough Aggravated? - 9 seconds ago
- Could Zofran cause Paraesthesia Oral? - 10 seconds ago
- Could Zofran cause Urine Abnormality? - 12 seconds ago
- Could Sutent cause Skin Reaction? - 16 seconds ago
- Could Zofran cause Myocardial Ischaemia? - 17 seconds ago
- Gastroesophageal Reflux Disease in Prazosin Hydrochloride, how severe and when it was recovered? - 17 seconds ago